Table 3 Summary of TEAEs (safety population)
TEAEs | Number of cases (%) |
|---|---|
Total number of TEAEs | 51 |
TEAEs | |
Grade 1 | 23 (51) |
Grade 2 | 17 (38) |
Grade 3 | 5 (11) |
Grade 4 | 6 (13) |
TEAEs leading to treatment discontinuation | 2 |
Deaths | 4 |
Treatment-related | 1 |
Treatment-related TEAEs reported in > 1 patient | |
Sensory neuropathy | 8 (18) |
Myalgia | 6 (13) |
Fatigue | 4 (9) |
Neutropenia | 4 (9) |
Anorexia | 2 (4) |
General weakness | 2 (4) |
Headache | 2 (4) |
Insomnia | 2 (4) |
Pneumonia | 2 (4) |
Sepsis | 2 (4) |
Tinnitus | 2 (4) |
Urticaria | 2 (4) |